Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: Proacta, Incorporated
Condition: Unspecified Adult Solid Tumor, Protocol Specific
NCT01631279
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
Study was prematurely discontinued due to unacceptable toxicity.